The revised warnings bring Litfulo in line with other JAK inhibitors, which are known to have an increased risk for serious side effects, including cardiovascular issues, blood cl ...

Phase 2 Data Boosts Investor Confidence Q32 Bio Inc. (NASDAQ:QTTB) shares surged 60% on Monday after the biotechnology ...

Two posters presented at the Society for Pediatric Dermatology Annual Meeting explored common health conditions linked to childhood alopecia areata and the effectiveness of dupilumab treatment in ...

Alopecia areata is an autoimmune skin disease that causes patchy spots of hair loss on the scalp and other parts of the body. Treatments vary depending on the severity of the condition, and every ...

Autologous fat grafting offers hope for patients with alopecia, especially those with scarring, by reducing inflammation and stimulating hair growth. Patients with alopecia are either diagnosed with ...

Q32 Bio (NASDAQ:QTTB) reported positive 36-week top-line results from Part B of its SIGNAL-AA Phase 2a clinical trial ...

Nearly two years after clinical setbacks cratered Q32’s stock price, new results showed hair growth improvements that ...

Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin ...

A national survey found broad consensus among hair experts on the use of intralesional corticosteroid (ILC) injections for alopecia but highlighted inconsistencies in dosing and injection parameters.

Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin ...

Alopecia areata is an autoimmune disorder that usually results in unpredictable, patchy hair loss. Approximately 7 million people in the U.S. have alopecia areata, and it can affect anyone of any age ...

The biotech's Phase 2a study of bempikibart showed a 35.3% mean reduction in hair loss scores, with the company planning a ...